Role of Dehydroepiandrosterone in Experimental and Human Carcinogenesis

This publication has 84 references indexed in Scilit:

• Dehydroepiandrosterone protects low density lipoproteins against peroxidation by free radicals produced by γ-radiolysis of ethanol–water mixtures
  Atherosclerosis, 1998
• Comparison of the Enhancing Effects of Dehydroepiandrosterone with the Structural Analog 16α-Fluoro-5-androsten-17-one on Aflatoxin B1Hepatocarcinogenesis in Rainbow Trout
  Fundamental and Applied Toxicology, 1996
• GH inhibition of lipogenesis and stimulation of lipolysis in sheep adipose tissue: involvement of protein serine phosphorylation and dephosphorylation and phospholipase C
  Journal of Endocrinology, 1996
• Effect of nicardipine, a calcium antagonist, on induction of peroxisomal enzymes by dehydroepiandrosterone sulfate in cultured rat hepatocytes.
  The Journal of Toxicological Sciences, 1996
• Adrenal glands of mouse and rat do not synthesize androgens
  Life Sciences, 1992
• Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon
  Cancer Letters, 1991
• Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16α-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides
  Carcinogenesis: Integrative Cancer Research, 1991
• Investigation into the effect of DHEA on renal carcinogenesis induced in the rat by a single dose of DMN
  Nutrition and Cancer, 1990
• Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides
  Life Sciences, 1986
• Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats
  Carcinogenesis: Integrative Cancer Research, 1985